These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4970399)

  • 21. N-terminal-capturing screening system for the isolation of Brucella abortus genes encoding surface exposed and secreted proteins.
    Marchesini MI; Ugalde JE; Czibener C; Comerci DJ; Ugalde RA
    Microb Pathog; 2004 Aug; 37(2):95-105. PubMed ID: 15312849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lysogenic variations of Brucella abortus. II. Variations obtained in vitro].
    Valerianov Ts; Koshkov A; Sokolova E
    Izv Mikrobiol Inst (Sofiia); 1971; 22():89-93. PubMed ID: 5005071
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines.
    Grilló MJ; Bosseray N; Blasco JM
    Biologicals; 2000 Jun; 28(2):119-27. PubMed ID: 10885618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the urease operon of Brucella abortus and assessment of its role in virulence of the bacterium.
    Sangari FJ; Seoane A; Rodríguez MC; Agüero J; García Lobo JM
    Infect Immun; 2007 Feb; 75(2):774-80. PubMed ID: 17101645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic value of the protein antigens of Br. abortus and Yersinia enterocolitica type 9].
    Kostov G; Bozilov B; Todorova P; Todorov T
    Vet Med Nauki; 1980; 17(5):60-6. PubMed ID: 6165133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic beta-1,2-glucan is a Brucella virulence factor required for intracellular survival.
    Arellano-Reynoso B; Lapaque N; Salcedo S; Briones G; Ciocchini AE; Ugalde R; Moreno E; Moriyón I; Gorvel JP
    Nat Immunol; 2005 Jun; 6(6):618-25. PubMed ID: 15880113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biochemical and electron microscopic study of the oxidative-reductive activity of cells of Brucella abortus-10 "L" of differing virulence].
    Dranovskaia EA; Vysotskiĭ VV
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Feb; 44(2):74-8. PubMed ID: 4973048
    [No Abstract]   [Full Text] [Related]  

  • 28. On lactosepositive variants of Sh. flexneri 2a and serotype 145-46.
    Trifonova A; Tekelieva R
    Zentralbl Bakteriol Orig; 1969 Jan; 209(2):196-203. PubMed ID: 5386532
    [No Abstract]   [Full Text] [Related]  

  • 29. Trimming the fat: a Brucella abortus survival strategy.
    Roy CR
    Nat Immunol; 2005 Jun; 6(6):546-8. PubMed ID: 15908934
    [No Abstract]   [Full Text] [Related]  

  • 30. [A comparative study of the activity of various enzyme systems of Br. abortus of varying virulence in a single genetic line].
    Dranovskaia EA; Dubrovskaia II
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jan; 46(1):108-12. PubMed ID: 4977811
    [No Abstract]   [Full Text] [Related]  

  • 31. Properties of an immunogenic fraction from Brucella abortus 45/20.
    Corbel MJ; Redwood DW
    Dev Biol Stand; 1984; 56():159-68. PubMed ID: 6436092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. THE RELATION BETWEEN RESISTANCE TO HYDROGEN PEROXIDE AND VIRULENCE IN BRUCELLAE.
    FITZGEORGE RB; KEPPIE J; SMITH H
    J Pathol Bacteriol; 1965 Apr; 89():745-7. PubMed ID: 14320320
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential composition of culture supernatants from wild-type Brucella abortus and its isogenic virB mutants.
    Delpino MV; Comerci DJ; Wagner MA; Eschenbrenner M; Mujer CV; Ugalde RA; Fossati CA; Baldi PC; Delvecchio VG
    Arch Microbiol; 2009 Jul; 191(7):571-81. PubMed ID: 19436993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual virulence of Brucella abortus in the absence of the cytochrome bc(1)complex in a murine model in vitro and in vivo.
    Ko J; Splitter GA
    Microb Pathog; 2000 Sep; 29(3):191-200. PubMed ID: 10968951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular trafficking study of a RB51 B. abortus vaccinal strain isolated from cow milk.
    Arellano-Reynoso B; Díaz-Aparicio E; Leal-Hernández M; Hernández L; Gorvel JP
    Vet Microbiol; 2004 Mar; 98(3-4):307-12. PubMed ID: 15036539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The cytochromes of brucellae].
    Dranovskaia EA; Kushnarev VM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Dec; 45(12):3-5. PubMed ID: 4979815
    [No Abstract]   [Full Text] [Related]  

  • 38. A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.
    Spera JM; Ugalde JE; Mucci J; Comerci DJ; Ugalde RA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16514-9. PubMed ID: 17053080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Action of bacteriophages on Brucella abortus and on Brucella suis].
    Gargani G
    Boll Ist Sieroter Milan; 1965; 44(7):189-201. PubMed ID: 4954320
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of Brucella abortus lipopolysaccharide macrodomains as mega rafts.
    Lapaque N; Forquet F; de Chastellier C; Mishal Z; Jolly G; Moreno E; Moriyon I; Heuser JE; He HT; Gorvel JP
    Cell Microbiol; 2006 Feb; 8(2):197-206. PubMed ID: 16441431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.